keyword
https://read.qxmd.com/read/38385208/psoriasiform-dermatitis-following-ocrelizumab-in-relapsing-remitting-multiple-sclerosis-case-report-and-literature-review
#1
JOURNAL ARTICLE
Callanan Emma, Petkova Vesela, Polly Kay, Huseyin Huseyin, Hassett Alison, Sittampalam Mara, De Angelis Floriana, Collorone Sara
We present a case of a 30-year-old man with relapsing-remitting multiple sclerosis who developed psoriasiform dermatitis following his second course of ocrelizumab. This resolved with topical therapies and discontinuation of treatment. Cases of psoriasiform rashes have been increasingly reported in the use of ocrelizumab and are possibly due to B-cell (CD20) depletion and T-cell overregulation. Nevertheless, skin-related adverse reactions are not yet considered in the risk management plans of anti-CD20 treatments in multiple sclerosis...
February 22, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/37083177/the-negative-impact-of-pain-catastrophising-on-disease-activity-analyses-of-data-derived-from-patient-reported-outcomes-in-psoriatic-arthritis-and-axial-spondyloarthritis
#2
JOURNAL ARTICLE
Damiano Currado, Alice Biaggi, Andrea Pilato, Annalisa Marino, Piero Ruscitti, Ilenia Pantano, Stefano Di Donato, Marta Vomero, Onorina Berardicurti, Viktoriya Pavlych, Claudio Di Vico, Francesco Caso, Luisa Costa, Marco Tasso, Federica Camarda, Francesca Misceo, Francesco De Vincenzo, Addolorata Corrado, Francesco Paolo Cantatore, Federico Perosa, Giuliana Guggino, Raffaele Scarpa, Paola Cipriani, Francesco Ciccia, Roberto Giacomelli, Luca Navarini
OBJECTIVES: Psychosocial factors are recognised as important determinants of pain experience in patients with inflammatory arthritides. Among them, pain catastrophising, a maladaptive cognitive style, observed in patients with anxiety and depressive disorders, garnered specific attention. Here, we evaluated pain catastrophising (PC) and its related domains (Rumination, Magnification, and Helplessness), in psoriatic arthritis (PsA) and axial spondyloarhtiritis (axSpA) participants, to assess its impact on disease activity...
April 13, 2023: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/36405606/a-deep-learning-based-approach-toward-differentiating-scalp-psoriasis-and-seborrheic-dermatitis-from-dermoscopic-images
#3
JOURNAL ARTICLE
Zhang Yu, Shen Kaizhi, Han Jianwen, Yu Guanyu, Wang Yonggang
OBJECTIVES: This study aims to develop a new diagnostic method for discriminating scalp psoriasis and seborrheic dermatitis based on a deep learning (DL) model, which uses the dermatoscopic image as input and achieved higher accuracy than dermatologists trained with dermoscopy. METHODS: A total of 1,358 pictures (obtained from 617 patients) with pathological and diagnostic confirmed skin diseases (508 psoriases, 850 seborrheic dermatitides) were randomly allocated into the training, validation, and testing datasets (1,088/134/136) in this study...
2022: Frontiers in Medicine
https://read.qxmd.com/read/36332938/peripheral-spondyloarthritis-and-psoriatic-arthritis-i-sine-psoriase-i-are-we-dealing-with-semantics-or-clinically-meaningful-differences
#4
REVIEW
Nelly Ziade, Michel Bou Absi, Xenofon Baraliakos
Diagnosing peripheral spondyloarthritis (pSpA) remains a significant challenge due to the lack of specific disease biomarkers and the overlap with other SpA subtypes, mainly psoriatic arthritis (PsA), which represents a diagnostic challenge particularly in the absence of skin psoriasis (PsA <i>sine psoriase</i>). This narrative review aimed to compare the epidemiology, genetic susceptibility, pathophysiology, classification criteria, disease phenotype and burden, and therapeutic guidelines between patients diagnosed with pSpA and those with PsA <i>sine psoriase,</i> to determine if the two entities should be considered jointly or distinctly...
November 2022: RMD Open
https://read.qxmd.com/read/35537933/expert-recommendations-for-the-use-of-apremilast-in-psoriatic-arthritis
#5
JOURNAL ARTICLE
Juan Carlos Torre Alonso, Raquel Almodóvar González, Carlos Montilla Morales, Jesús Sanz Sanz, Federico Díaz González, Eva Pascual Alfonso, Jordi Gratacós
INTRODUCTION AND OBJECTIVES: Despite the evidence, there are doubts about the positioning of apremilast in the psoriatic arthritis (PsA) treatment algorithm. The objective of this project was to collect the scientific evidence and the experience of a group of rheumatologists who are experts in the management of PsA with apremilast in clinical practice in Spain. MATERIAL AND METHODS: A scientific committee made up of 6 experts proposed 5 clinical scenarios where the evidence on the use of apremilast in PsA was controversial: (i) Efficacy in peripheral PsA; (ii) Efficacy in enthesitis and dactylitis; (iii) Efficacy in PsA with skin involvement; (iv) Comorbidities; and (v) Apremilast safety...
May 7, 2022: Reumatología clinica
https://read.qxmd.com/read/34565644/brazilian-consensus-on-psoriasis-2020-and-treatment-algorithm-of-the-brazilian-society-of-dermatology
#6
JOURNAL ARTICLE
Ricardo Romiti, André Vicente E de Carvalho, Gleison V Duarte
No abstract text is available yet for this article.
2021: Anais Brasileiros de Dermatologia
https://read.qxmd.com/read/32321338/psoriatic-arthritis-induced-by-anti-pd1-and-treated-with-apremilast-a-case-report-and-review-of-the-literature
#7
REVIEW
Olga Nigro, Graziella Pinotti, Rossana Gueli, Elena Grigioni, Maria De Santis, Angela Ceribelli, Carlo Selmi
Immune checkpoint inhibitors targeting programmed cell death protein 1 pathways are generally well tolerated, but immune-related adverse events have been observed in more than 80% of all patients. Rheumatic and musculoskeletal immune related adverse events have to date not been widely recognized or well characterized. Psoriasic arthritis is a rare entity and it makes management of patients difficult due to the limited therapeutic possibilities and the strong impact on the quality of life. The majority of cases were treated with glucocorticoids, in some cases not enough...
June 2020: Immunotherapy
https://read.qxmd.com/read/30365667/use-of-active-metabolites-of-vitamin-d-orally-for-the-treatment-of-psoriasis
#8
REVIEW
Mayara Lourencetti, Marida Morgado de Abreu
OBJECTIVE: The objective of this study was to analyse the existing bibliographic production on clinical trials related to the use of vitamin D for oral treatment of psoriasis. METHOD: A literature review of clinical trials related to the use of vitamin D for oral treatment of psoriasis, published in the LILACS, Scielo, Medline, PubMed and Cochrane Library from 1986 to 2013. The search included the following terms: "Psoriasis and oral Vitamin D"; "psoríase e vitamina D oral"...
July 2018: Revista da Associação Médica Brasileira
https://read.qxmd.com/read/29864894/mir-876-5p-suppresses-cell-proliferation-by-targeting-angiopoietin-1-in-the-psoriasis
#9
JOURNAL ARTICLE
Rongna A, Pei Yu, Siyu Hao, Yuzhen Li
Psoriasis is an autoimmune disease characterized by abnormal differentiation and hyper-proliferation of epidermal keratinocytes. The object of the study is to investigate the role of miRNA-876-5p in psoriasis. It reported that MicroRNAs (miRNAs) played roles in the malignant progression in psoriasis development. The expression of miR-876-5p was found to be down-regulated in psoriasic tissue and blood of patients. The luciferase assay verified the targeting role of miR-876-5p to 3'UTR of Angiopoietin-1 (Ang-1)...
July 2018: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/27055672/development-and-validation-of-a-bayesian-network-for-the-differential-diagnosis-of-anterior-uveitis
#10
JOURNAL ARTICLE
J J González-López, Á M García-Aparicio, D Sánchez-Ponce, N Muñoz-Sanz, N Fernandez-Ledo, P Beneyto, M C Westcott
PurposeTo develop and validate a Bayesian belief network algorithm for the differential diagnosis of anterior uveitis.Patients and methodsThe 11 most common etiologies were included (idiopathic, ankylosing spondylitis, psoriasic arthritis, reactive arthritis, inflammatory bowel diseases, sarcoidosis, tuberculosis, Behçet, Posner-Schlossman syndrome, juvenile idiopathic arthritis (JIA), and Fuchs' heterochromic cyclitis). Frequencies of association between factors and etiologies were retrieved from a systematic review of the literature...
June 2016: Eye
https://read.qxmd.com/read/24772805/-comorbidities-in-psoriasic-arthritis
#11
REVIEW
S Zürcher, W-H Boehncke, S Boehncke
Psoriatic arthritis occurs almost exclusively together with psoriasis of the skin. It seems useful therefore for the practitioner to consider the two of them as manifestations of one "psoriatic disease". This pragmatic approach is more contemporary, particularly since it is increasingly clear that the "psoriatic disease" goes beyond damage to the skin and joints. The most important "comorbidities" associated with psoriatic disease are presented here; especially the cardiovascular diseases as well as their risk factors, namely smoking, obesity, and the metabolic syndrome...
April 2, 2014: Revue Médicale Suisse
https://read.qxmd.com/read/24442045/psoriasis-or-psoriases
#12
EDITORIAL
A Balato, L Di Costanzo, C Patruno, F Ayala, M Megna, N Balato
No abstract text is available yet for this article.
December 2013: Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Società Italiana di Dermatologia e Sifilografia
https://read.qxmd.com/read/23572784/processing-food-applications-and-safety-of-aloe-vera-products-a-review
#13
JOURNAL ARTICLE
Kulveer Singh Ahlawat, Bhupender Singh Khatkar
Aloe vera is used for vigor, wellness and medicinal purposes since rigvedic times. Health benefits of aloe vera include its application in wound healing, treating burns, minimizing frost bite damage, protection against skin damage from x-rays, lung cancer, intestinal problems, increasing high density lipoprotein (HDL), reducing low density lipoprotein (LDL), reducing blood sugar in diabetics, fighting acquired immune deficiency syndrome (AIDS), allergies and improving immune system. Phytochemistry of aloe vera gel has revealed the presence of more than 200 bioactive chemicals...
October 2011: Journal of Food Science and Technology
https://read.qxmd.com/read/23282275/-guillain-barr%C3%A3-syndrome-its-association-with-alpha-tumor-necrosis-factor
#14
JOURNAL ARTICLE
Elizabeth Soto-Cabrera, Alejandro Hernández-Martínez, Hiram Yáñez, Raúl Carrera
BACKGROUND: adalimumab, a human recombinant monoclonal antibody against tumoral necrosis factor alpha (TNFα), has been associated with central nervous system demyelinating diseases and peripheral neuropathic syndrome. The Guillain-Barré Syndrome (GBS) is one of them. CLINICAL CASE: we presented the case of a 65 year old woman, with diabetes mellitus and psoriasic arthritis, treated with adalimumab; after the fourth infusion, she developed paresthesia and mild weakness in lower limbs, these symptoms persisted three days after each infusion and each time remitted spontaneously; following the eight dose, presented a characteristic clinical picture of the GBS, confirmed with neurophysiological studies that showed an axonal motor-sensitive polyneuropathy...
September 2012: Revista Médica del Instituto Mexicano del Seguro Social
https://read.qxmd.com/read/22739986/anti-apoptotic-effects-of-suppressor-of-cytokine-signaling-3-and-1-in-psoriasis
#15
JOURNAL ARTICLE
S Madonna, C Scarponi, S Pallotta, A Cavani, C Albanesi
Because of their genetically determined capacity to respond to pro-inflammatory stimuli, keratinocytes have a crucial role in the pathogenesis of psoriasis. Upon IFN-γ and TNF-α exposure, psoriatic keratinocytes express exaggerated levels of inflammatory mediators, and show aberrant hyperproliferation and terminal differentiation. The thickening of psoriasic skin also results from a peculiar resistance of keratinocytes to cytokine-induced apoptosis. In this study, we investigated on the molecular mechanisms concurring to the resistance of psoriatic keratinocytes to cell death, focusing on the role having suppressor of cytokine signaling (SOCS)1 and SOCS3, two molecules abundantly expressed in IFN-γ/TNF-α-activated psoriatic keratinocytes, in sustaining anti-apoptotic pathways...
June 28, 2012: Cell Death & Disease
https://read.qxmd.com/read/22129323/metastatic-melanoma-in-a-young-woman-treated-with-tnf-%C3%AE-inhibitor-for-psoriatic-arthritis-a-case-report
#16
JOURNAL ARTICLE
Bianca Marasini, Luca Cozzaglio, Laura Belloli, Marco Massarotti, Nicola Ughi, Paolo Pedrazzoli
INTRODUCTION: The risk of cancer with the use of biologic agents in rheumatic diseases is still a matter of debate. Published data suggest that the extent of cancer risk might differ according to the type of cancer, and there is recent clinical evidence for a significant increased risk for skin cancer, including melanoma. In contrast with the extensive literature on cancer risk in rheumatoid arthritis, little has been reported on the development of malignancies in spondyloarthroparthies...
September 1, 2011: Current Drug Safety
https://read.qxmd.com/read/21930119/pathogenesis-and-pharmacotherapy-of-hidradenitis-suppurativa
#17
REVIEW
Maiwand Nazary, H H van der Zee, E P Prens, Gert Folkerts, Jurr Boer
The focus of this review is to discuss the pathogenesis and the pharmacotherapy of Hidradenitis suppurativa (HS). HS is a distressing chronic skin disorder characterized by abscesses, boils, fistulas and scarring, generally affecting the groins, anogenital area and axillae. It is a common disease with an estimated prevalence of 1%. The etiology is unknown. HS was thought to be a disease of the apocrine sweat glands, but histological findings indicate that HS is a disease arising from the hair follicles. Several pathogenic factors seem important including genetic predisposition, smoking, obesity and an aberrant immune response to commensal flora...
December 15, 2011: European Journal of Pharmacology
https://read.qxmd.com/read/21324346/expression-of-antimicrobial-peptides-and-proteins-in-etanercept-treated-psoriasis-patients
#18
JOURNAL ARTICLE
T Gambichler, S Kobus, A Kobus, C Tigges, N Scola, P Altmeyer, A Kreuter, F G Bechara, M Skrygan
Recent papers highlight the role of dysregulated expression of antimicrobial peptides and proteins (AMPs) in the pathogenesis of psoriasis. Etanercept, a blocker of the pro-inflammatory cytokine tumour necrosis factor-α (TNF-α), is effective in the treatment of psoriasis. We aimed to evaluate the expression profiles of AMPs in psoriatic skin before and after a 6-week course of etanercept therapy. We included 12 psoriasis patients who underwent medium-dose etanercept treatment for 6weeks. At baseline and at the end of therapy immunohistochemistry from lesional skin was performed for psoriasin, LL-37, and human ß-defensin 2 (hBD-2)...
April 11, 2011: Regulatory Peptides
https://read.qxmd.com/read/20599469/-active-who-class-iv-lupus-nephritis-in-a-patient-treated-with-etanercept-for-a-psoriasic-arthritis
#19
JOURNAL ARTICLE
Mathieu Sacquépée, Vincent Rouleau, Jean-François Cantin, Nicolas Quirin, Yves Doussy, Jean-Claude Valéry, Cristina Picu, Jean-Michel Tivollier
INTRODUCTION: Drug-induced lupus nephritis in patients treated with TNF α inhibitor is a rare adverse effect. Anti-TNF α therapies are commonly associated with the induction of auto-antibodies, whereas anti-TNF α-induced lupus is rare, most frequently involving arthritis and cutaneous lesions. However, several renal involvement has been reported. OBSERVATION: A 26-year old woman with a history of psoriasic arthritis treated with TNF α inhibitor (etanercept) presented with a biopsy-proved class IV lupus nephritis...
November 2010: Néphrologie & Thérapeutique
https://read.qxmd.com/read/20500689/the-role-of-microrna-146a-mir-146a-and-its-target-il-1r-associated-kinase-irak1-in-psoriatic-arthritis-susceptibility
#20
JOURNAL ARTICLE
A Chatzikyriakidou, P V Voulgari, I Georgiou, A A Drosos
MicroRNAs have shown different expression patterns in immune diseases. The present study explores the association of miRNA-146a variant rs2910164 and of two IRAK1 (target of miR-146a) polymorphisms rs3027898 and rs1059703 with psoriasic arthritis (PsA). Twenty-nine PsA and 66 controls were enrolled in the study. To study if the statistical significant differences between patients with PsA and controls are independent to psoriasis, we expanded the study in 49 patients with ankylosing spondylitis (AS). Strong statistical significant difference was observed in IRAK1 rs3027898 polymorphism distribution between patients with PsA and controls (P = 0...
May 2010: Scandinavian Journal of Immunology
keyword
keyword
167067
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.